色素-话题@MedSci

#色素#

654篇内容 | 6215人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1680527, encodeId=9350168052e8c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=恶性黑色素瘤右室转移1例, objectType=article, longId=138566, objectId=084f138566d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=084f138566d0, replyNumber=0, likeNumber=70, createdTime=2018-10-12, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=084f138566d0, moduleTitle=恶性黑色素瘤右室转移1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=084f138566d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680553, encodeId=08411680553a4, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=PNAS重磅：100%的黑色素瘤完全消失！只需这两种药物联合使用！, objectType=article, longId=147968, objectId=9c2214e96805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c2214e96805, replyNumber=0, likeNumber=75, createdTime=2019-04-26, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c2214e96805, moduleTitle=PNAS重磅：100%的黑色素瘤完全消失！只需这两种药物联合使用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c2214e96805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680579, encodeId=df7616805e928, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CANCER RES：BRAF和HSP90抑制剂联合治疗不可切除的黑色素瘤, objectType=article, longId=154006, objectId=cf53154006f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf53154006f7, replyNumber=0, likeNumber=76, createdTime=2019-05-29, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf53154006f7, moduleTitle=CLIN CANCER RES：BRAF和HSP90抑制剂联合治疗不可切除的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf53154006f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680538, encodeId=4af51680538f9, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Exp Eye Res：葡萄膜黑色素细胞高表达MMP-8并受MAPK途径调控, objectType=article, longId=142190, objectId=c43a142190b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c43a142190b3, replyNumber=0, likeNumber=85, createdTime=2019-02-03, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c43a142190b3, moduleTitle=Exp Eye Res：葡萄膜黑色素细胞高表达MMP-8并受MAPK途径调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c43a142190b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680597, encodeId=d2be168059e38, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Exp Ther Med：加权基因共表达网络分析发现泛素介导的蛋白水解为葡萄膜黑色素瘤潜在生物标志物, objectType=article, longId=159903, objectId=713f1599037f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713f1599037f, replyNumber=0, likeNumber=76, createdTime=2019-07-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713f1599037f, moduleTitle=Exp Ther Med：加权基因共表达网络分析发现泛素介导的蛋白水解为葡萄膜黑色素瘤潜在生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=713f1599037f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680608, encodeId=78cb16806080b, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NCCN临床实践指南：皮肤黑色素瘤（2019.V2）, objectType=article, longId=163793, objectId=aff7163e9318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aff7163e9318, replyNumber=0, likeNumber=11, createdTime=2019-11-05, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aff7163e9318, moduleTitle=NCCN临床实践指南：皮肤黑色素瘤（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aff7163e9318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680531, encodeId=c8111680531c8, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=DISCOV MED：晚期黑色素瘤抗PD-1单抗治疗, objectType=article, longId=139128, objectId=5542139128bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5542139128bc, replyNumber=0, likeNumber=74, createdTime=2018-05-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5542139128bc, moduleTitle=DISCOV MED：晚期黑色素瘤抗PD-1单抗治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5542139128bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680564, encodeId=13e0168056466, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Life Sci：隐色素1通过Wnt/β-连环蛋白信号传导促进人成骨细胞的成骨分化, objectType=article, longId=150480, objectId=99a4150480b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99a4150480b8, replyNumber=0, likeNumber=59, createdTime=2019-02-22, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99a4150480b8, moduleTitle=Life Sci：隐色素1通过Wnt/β-连环蛋白信号传导促进人成骨细胞的成骨分化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99a4150480b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680565, encodeId=346516805655c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lasers Med Sci：Wnt/β-catenin信号通路在激光光凝术后诱导多能干细胞衍生视网膜色素上皮细胞的恢复过程中具有重要作用, objectType=article, longId=150778, objectId=b05d150e78dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b05d150e78dd, replyNumber=0, likeNumber=113, createdTime=2019-03-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b05d150e78dd, moduleTitle=Lasers Med Sci：Wnt/β-catenin信号通路在激光光凝术后诱导多能干细胞衍生视网膜色素上皮细胞的恢复过程中具有重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b05d150e78dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680522, encodeId=87ef16805227c, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Int J Mol Med：新型NADPH氧化酶抑制剂VAS2870可抑制视网膜色素上皮细胞中TGF-β依赖的上皮-间质转化过程, objectType=article, longId=136514, objectId=8d591365143e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d591365143e, replyNumber=0, likeNumber=64, createdTime=2018-11-18, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d591365143e, moduleTitle=Int J Mol Med：新型NADPH氧化酶抑制剂VAS2870可抑制视网膜色素上皮细胞中TGF-β依赖的上皮-间质转化过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d591365143e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680511, encodeId=18ed168051154, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet Oncol：转移性黑色素瘤患者：肥胖不再是“催命符”？, objectType=article, longId=133551, objectId=32e513355160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32e513355160, replyNumber=0, likeNumber=57, createdTime=2018-10-31, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32e513355160, moduleTitle=Lancet Oncol：转移性黑色素瘤患者：肥胖不再是“催命符”？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32e513355160)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680588, encodeId=390f168058830, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=黑色素瘤诊疗规范（2018年版）, objectType=article, longId=156786, objectId=3f12156e8689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f12156e8689, replyNumber=0, likeNumber=11, createdTime=2019-03-06, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f12156e8689, moduleTitle=黑色素瘤诊疗规范（2018年版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f12156e8689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680506, encodeId=2a93168050666, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet oncol：尼洛替尼（nilotinib），CSF1R酪氨酸激酶抑制剂，可控制色素性绒毛结节性滑膜炎患者的病程进展, objectType=article, longId=133036, objectId=740813303624, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=740813303624, replyNumber=0, likeNumber=11, createdTime=2018-06-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=740813303624, moduleTitle=Lancet oncol：尼洛替尼（nilotinib），CSF1R酪氨酸激酶抑制剂，可控制色素性绒毛结节性滑膜炎患者的病程进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=740813303624)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680520, encodeId=c10b168052051, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=JAMA Dermatol：单身狗暴击！脱单竟然可以抵抗黑色素瘤！, objectType=article, longId=136170, objectId=2c471361e083, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c471361e083, replyNumber=0, likeNumber=64, createdTime=2018-09-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c471361e083, moduleTitle=JAMA Dermatol：单身狗暴击！脱单竟然可以抵抗黑色素瘤！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c471361e083)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680577, encodeId=2e1316805e742, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=NEJM：支气管黑色素瘤-病例报道, objectType=article, longId=153568, objectId=c60215356889, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c60215356889, replyNumber=0, likeNumber=96, createdTime=2019-08-21, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c60215356889, moduleTitle=NEJM：支气管黑色素瘤-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c60215356889)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680533, encodeId=cca61680533f0, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=【2018 ASCO】“治愈”卡特总统的恶性黑色素瘤免疫治疗新进展, objectType=article, longId=139779, objectId=a99d139e7926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a99d139e7926, replyNumber=0, likeNumber=141, createdTime=2019-05-01, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99d139e7926, moduleTitle=【2018 ASCO】“治愈”卡特总统的恶性黑色素瘤免疫治疗新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a99d139e7926)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680504, encodeId=dcda1680504e2, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Nat Commun：黑色素瘤耐药机制研究取得突破性进展, objectType=article, longId=132062, objectId=19f613206219, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19f613206219, replyNumber=0, likeNumber=62, createdTime=2018-07-08, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19f613206219, moduleTitle=Nat Commun：黑色素瘤耐药机制研究取得突破性进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19f613206219)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680530, encodeId=00611680530dd, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=CLIN CHEM：黑色素瘤患者血浆中循环肿瘤DNA的液体分析用于伴随诊断和BRAF抑制剂治疗的监测, objectType=article, longId=138830, objectId=1e7b1388303f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7b1388303f, replyNumber=0, likeNumber=61, createdTime=2018-08-02, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7b1388303f, moduleTitle=CLIN CHEM：黑色素瘤患者血浆中循环肿瘤DNA的液体分析用于伴随诊断和BRAF抑制剂治疗的监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e7b1388303f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680562, encodeId=d8d21680562b4, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=PNAS：科学家测试新抗黑色素瘤癌症疫苗, objectType=article, longId=149718, objectId=be85149e186c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be85149e186c, replyNumber=0, likeNumber=107, createdTime=2019-02-07, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be85149e186c, moduleTitle=PNAS：科学家测试新抗黑色素瘤癌症疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be85149e186c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1680558, encodeId=d44d168055864, content=<a href='/topic/show?id=9e5c86e0712' target=_blank style='color:#2F92EE;'>#色素#</a>, objectTitle=Lancet oncol：Encorafenib联合binimetinib治疗BRAF突变型黑色素瘤总体存活率效益显著, objectType=article, longId=148780, objectId=15b2148e8062, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15b2148e8062, replyNumber=0, likeNumber=101, createdTime=2019-05-06, rootId=0, userName=sunylz, userId=343027846633, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15b2148e8062, moduleTitle=Lancet oncol：Encorafenib联合binimetinib治疗BRAF突变型黑色素瘤总体存活率效益显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15b2148e8062)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

色素

2020-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

恶性黑色素瘤右室转移1例

2018-10-12

sunylz (审核中...)

前往app查看评论内容

#色素#

PNAS重磅：100%的黑色素瘤完全消失！只需这两种药物联合使用！

2019-04-26

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CANCER RES：BRAF和HSP90抑制剂联合治疗不可切除的黑色素瘤

2019-05-29

sunylz (审核中...)

前往app查看评论内容

#色素#

Exp Eye Res：葡萄膜黑色素细胞高表达MMP-8并受MAPK途径调控

2019-02-03

sunylz (审核中...)

前往app查看评论内容

#色素#

Exp Ther Med：加权基因共表达网络分析发现泛素介导的蛋白水解为葡萄膜黑色素瘤潜在生物标志物

2019-07-21

sunylz (审核中...)

前往app查看评论内容

#色素#

NCCN临床实践指南：皮肤黑色素瘤（2019.V2）

2019-11-05

sunylz (审核中...)

前往app查看评论内容

#色素#

DISCOV MED：晚期黑色素瘤抗PD-1单抗治疗

2018-05-31

sunylz (审核中...)

前往app查看评论内容

#色素#

Life Sci：隐色素1通过Wnt/β-连环蛋白信号传导促进人成骨细胞的成骨分化

2019-02-22

sunylz (审核中...)

前往app查看评论内容

#色素#

Lasers Med Sci：Wnt/β-catenin信号通路在激光光凝术后诱导多能干细胞衍生视网膜色素上皮细胞的恢复过程中具有重要作用

2019-03-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Int J Mol Med：新型NADPH氧化酶抑制剂VAS2870可抑制视网膜色素上皮细胞中TGF-β依赖的上皮-间质转化过程

2018-11-18

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet Oncol：转移性黑色素瘤患者：肥胖不再是“催命符”？

2018-10-31

sunylz (审核中...)

前往app查看评论内容

#色素#

黑色素瘤诊疗规范（2018年版）

2019-03-06

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet oncol：尼洛替尼（nilotinib），CSF1R酪氨酸激酶抑制剂，可控制色素性绒毛结节性滑膜炎患者的病程进展

2018-06-21

sunylz (审核中...)

前往app查看评论内容

#色素#

JAMA Dermatol：单身狗暴击！脱单竟然可以抵抗黑色素瘤！

2018-09-02

sunylz (审核中...)

前往app查看评论内容

#色素#

NEJM：支气管黑色素瘤-病例报道

2019-08-21

sunylz (审核中...)

前往app查看评论内容

#色素#

【2018 ASCO】“治愈”卡特总统的恶性黑色素瘤免疫治疗新进展

2019-05-01

sunylz (审核中...)

前往app查看评论内容

#色素#

Nat Commun：黑色素瘤耐药机制研究取得突破性进展

2018-07-08

sunylz (审核中...)

前往app查看评论内容

#色素#

CLIN CHEM：黑色素瘤患者血浆中循环肿瘤DNA的液体分析用于伴随诊断和BRAF抑制剂治疗的监测

2018-08-02

sunylz (审核中...)

前往app查看评论内容

#色素#

PNAS：科学家测试新抗黑色素瘤癌症疫苗

2019-02-07

sunylz (审核中...)

前往app查看评论内容

#色素#

Lancet oncol：Encorafenib联合binimetinib治疗BRAF突变型黑色素瘤总体存活率效益显著

2019-05-06

科室
- - 订阅+
  - 更多科室
工具
服务